From YMB “Barring unforeseen announcements, t
Post# of 155537
(Total Views: 1126)
Posted On: 09/01/2022 3:20:44 PM
From YMB
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com